Study Reveals Why Most Smokers Avoid Lung Cancer Despite Tobacco Use

Recent research has shed light on the puzzling phenomenon that only a minority of smokers develop lung cancer, despite the well-documented risks associated with tobacco use. The study suggests that certain smokers have inherent defense mechanisms that protect their DNA from the harmful effects of tobacco, thereby preventing the onset of lung cancer. This discovery not only deepens our understanding of cancer prevention but also opens new avenues for developing targeted treatments for those who do develop the disease.

For individuals who are not protected by these natural defenses, the findings underscore the importance of accessible and effective treatment options. Companies like Calidi Biotherapeutics Inc. are at the forefront of exploring innovative therapies to combat lung cancer, highlighting the critical role of ongoing research and development in addressing this global health challenge.